ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IMM Immupharma Plc

2.125
-0.05 (-2.30%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Immupharma Plc LSE:IMM London Ordinary Share GB0033711010 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.05 -2.30% 2.125 2.10 2.15 2.22 2.10 2.22 642,577 16:35:17
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 0 -3.81M -0.0114 -1.84 7M
Immupharma Plc is listed in the Finance Services sector of the London Stock Exchange with ticker IMM. The last closing price for Immupharma was 2.18p. Over the last year, Immupharma shares have traded in a share price range of 0.83p to 3.78p.

Immupharma currently has 333,403,115 shares in issue. The market capitalisation of Immupharma is £7 million. Immupharma has a price to earnings ratio (PE ratio) of -1.84.

Immupharma Share Discussion Threads

Showing 38976 to 38999 of 39125 messages
Chat Pages: 1565  1564  1563  1562  1561  1560  1559  1558  1557  1556  1555  1554  Older
DateSubjectAuthorDiscuss
19/6/2023
08:09
Results will be a lot sooner than 2027. And yes I work in pharma too.
photon
19/6/2023
07:55
Sell off news no one is hanging around.
johnjames876
19/6/2023
07:46
Thankfully the markets are forward-looking Nobby.
the imperialist
19/6/2023
07:26
So just to temper enthusiasm I expect we will get the results in early 2027 so approval at the earliest will be in 2028!
nobbygnome
19/6/2023
07:12
This is excellent news. Today should see some significant upside.
manual dexterity
19/6/2023
07:11
So the dosing is ‘at much higher concentrations’; than before! If only the company had listened to me all those years ago when I told them their own data indicated they needed a much higher concentration. The stick I got from some aggressive BB posters was appalling including one who threatened to come round to my house and sort me out!

Indeed I wonder if the FDA’s change in stance was down to me. Around 3 years ago I sent an email containing all the documentary evidence to the FDA. I just got a standard reply so of course don’t know if anyone took notice of it but in the interim they completely changed their position.

Anyway shareholders should rightly hold McCarthy to account because he was the Chairman at the time…..

nobbygnome
16/6/2023
11:50
It has been said 'no news is good news'; not sure this is true for IMM but as usual it is wait and see.
colsmith
16/6/2023
08:49
Still no news and share price drifts ...really not sure if i should just get out now
lee181067
13/6/2023
13:58
zilch - it'll be RNS'd. And you can bet your bottom dollar this board will then immediately be drowned in commentary (most of it irrational).
lord loads of lolly
13/6/2023
12:33
any news from the FDA Meeting last week ?
johneee
08/6/2023
17:59
Probably 'cos some expected an RNS the day after their scheduled FDA meeting. To be fair to Tim (& I rarely am, 'cos he's useless), he did say those meeting dates were only estimates and that things could slide. And we're quite used to things sliding at IMM (mainly the share price).
lord loads of lolly
08/6/2023
16:46
Clearly not good as price is going down..but why if no info???
lee181067
08/6/2023
09:40
No RNS yet = no update.
lord loads of lolly
08/6/2023
09:05
Has there been any update on the meeting due to take place yesterday
lee181067
02/6/2023
08:48
Bring on June 7th ----------- Lupazor phase 3 FDA approval meeting

If that is positive ........watch this FLY

More than Fingers Crossed for everyone

johneee
31/5/2023
20:27
LLOL-see what passes for analysis from him on LSE and weep.
clintdavid1
31/5/2023
15:39
I see Aridis Pharmaceuticals Inc were up over 170% today - must be to do with this ......

"Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS) today announced positive feedback from the FDA on the Company’s proposed single confirmatory Phase 3 study of investigational monoclonal antibody candidate AR-301 ......"

stockriser
31/5/2023
15:16
I've already learnt something, but many thanks for the thought LLOL
stockriser
31/5/2023
13:55
clintdavid1 - yes, then stockriser might actually learn something.
lord loads of lolly
31/5/2023
12:33
You should see what LLOL passes off as analysis!
clintdavid1
30/5/2023
09:28
You're very welcome LLOL
stockriser
30/5/2023
09:27
Stockriser - thanks for that detailed analysis.
lord loads of lolly
30/5/2023
08:46
Blue today me thinks ;-)

GLA SR

stockriser
20/5/2023
12:59
JUNE 7TH DECISION FDA LUPIZOR PHASE 3 TRIALS UNLOCKING $25M AND 70M ROYAL BACK ROYALTIES
purple11
Chat Pages: 1565  1564  1563  1562  1561  1560  1559  1558  1557  1556  1555  1554  Older

Your Recent History

Delayed Upgrade Clock